Replay available

MacroGenics, Inc. (MGNX) Q4 2023 Earnings Call

MacroGenics, Inc. (NASDAQ: MGNX) Q4 2023 earnings conference call, held 2024-03-07. Replay captured from the company's public earnings webcast.

Thu, March 7, 2024 at 4:30 PMendedReplay
MacroGenics, Inc. (MGNX) Q4 2023 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Jim Carroll

Senior Vice President, Chief Financial Officer, Macrogenics

Dr. Scott Koenig

President and Chief Executive Officer, Macrogenics

Jonathan Chang

Analyst, Levering Partners

Kelsey Goodwin

Analyst, Guggenheim

Steven Willie

Analyst, Stifel

Yagal Nakamovitz

Analyst, Citigroup

John Miller

Analyst, Evercore

Kaveri Pullman

Analyst, BTIG

Tara Bancroft

Analyst, TD Cowen

Pete Lawson

Analyst, Barclays

Sylvan Turkin

Analyst, Citizens JMP

Replay transcript excerpt

We will begin the Macrogenics 2023 Fourth Quarter Corporate Progress and Financial Results Conference Call in just a moment. All participants are in listen-only mode at the moment, and we will conduct a question and answer session at the conclusion of the call. At this point, I will turn the call over to Jim Carrolls, Senior Vice President, Chief Financial Officer of Macrogenics. Thank you, Operator. Good afternoon and welcome to the Macrogenics conference call to discuss our fourth quarter 2023 financial and operational results. For anyone who has not had the chance to review these results, we issued a press release this afternoon outlining today's announcements. This release is available under the Investors tab on our website at macrogenics.com. You may also listen to this conference call via webcast on our website, where it will be archived for 30 days beginning approximately two hours after the call is completed. I would like to alert listeners that today's discussion will include statements about the company's future expectations, plans, and prospects that constitute forward-looking statements for purposes of the safe harbor provision under this Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the risk factors section of our annual, quarterly, and current reports filed with the SEC. In addition, any forward-looking statements represent our views only as of today. It should not be relied upon as representative views as of any subsequent date. While we may elect to update these forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even if our views c...

More from Macrogenics, Inc.